Analysis of a peptide inhibitor of paramyxovirus (NDV) fusion using biological assays, NMR, and molecular modeling

Virology

Volumn 238, Issue 2, 1997, Pages 291-304

  Young, John K ^a   Hicks, Rickey P ^b   Wright, George E ^a   Morrison, Trudy G ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b MISSISSIPPI STATE UNIVERSITY   (United States)

Author keywords

Fusion; Molecular modeling; NDV; NMR; Paramyxovirus; Peptide

Indexed keywords

COMPLEMENTARY DNA; PROTEIN INHIBITOR; TRYPSIN; VIRUS FUSION PROTEIN; VIRUS HEMAGGLUTININ; VIRUS SIALIDASE;

AMINO ACID SEQUENCE; ANIMAL CELL; AQUEOUS SOLUTION; ARTICLE; CELL FUSION; CELL STRAIN COS1; CHICK EMBRYO; CONTROLLED STUDY; HYDROGEN BOND; MOLECULAR MODEL; NEWCASTLE DISEASE PARAMYXOVIRUS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CONFORMATION; PROTEIN SECONDARY STRUCTURE; PROTEIN STABILITY;

EID: 0031585556     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1997.8834     Document Type: Article

References (50)

1. Atta-ur-Rahman. One- and Two-Dimensional NMR Spectroscopy. 1989;Elsevier, Amsterdam.
2. Bax A., Davis D. G. MLEV-17-based two-dimensional homonuclear magnetization transfer spectroscopy. J. Magn. Reson. 65:1985;355-360.
3. Brasseur R., Pillot T., Lins L., Vandekerckhove J., Rosseneu M. Peptides in membranes: Tipping the balance of membrane stability. Trends Biochem. Sci. 22:1997;167-171.
4. Buckland R., Malvoisin E., Beauverger P., Wild F. A leucine zipper structure present in the measles virus fusion protein is not required for its tetramerization but is essential for fusion. J. Gen. Virol. 73:1992;1703-1707.
5. Buckland R., Wild F. Leucine zipper motif extends. Nature (London). 338:1989;547.
6. Bull T. E. ROESY relaxation theory. J. Magn. Reson. 80:1988;470-481.
7. Chambers P., Pringle C. R., Easton J. J. Heptad repeat sequences are located adjacent to hydrophobic regions in several types of virus fusion glycoproteins. J. Gen. Virol. 71:1990;3075-3080.
8. 1. J. Mol. Biol. 186:1985;435-455.
9. Creighton T. E. Proteins: Structure and Molecular Properties. 1984;Freeman, New York.
10. 1. J. Am. Chem. Soc. 107:1985;2820-2821.
11. Eich G., Bodenhausen G., Ernst R. R. Exploring nuclear spin systems by relayed magnetization transfer. J. Am. Chem. Soc. 104:1982;3731.
12. Gierasch L. M., Lacy J. E., Thompson K. F., Rockwell A. L., Watnick P. I. Conformations of model peptides in membrane-mimetic environments. Biophys. J. 37:1982;275-284.
13. Glickman R. L., Syddall R. J., Sheehan R. M., Bratt M. A. Quantitative basic residue requirements in the cleavage activation site of the fusion glycoprotein as a determinant of virulence of Newcastle disease virus. J. Virol. 62:1988;354-356.
14. Gonzalez L. J., Brown R. A., Richardson D., Alber T. Crystal structures of a single coiled-coil peptide in two oligomeric states reveal the basis for structural polymorphism. Nature Struct. Biol. 3:1996;1002-1010.
15. Harbury P. B., Zhang T., Kim P. S., Alber T. A switch between two-, three-, and four-stranded coiled coils in GCN4 leucine zipper mutants. Science. 262:1993;1401-1407.
16. Hernandez L. D., Hoffman L. R., Wolfsberg T. G., White J. M. Virus-cell and cell-cell fusion. Annu. Rev. Cell Biol. 12:1996;627-661.
17. Hicks R. P., Young J. K. Magnetization transfer via isotropic mixing: An introduction to the HOHAHA experiment. Concepts Magn. Reson. 6:1994;115-130.
18. Homans S. W. A Directory of Concepts in NMR. 1989;Clarendon Press, Oxford.
19. Hsu M., Scheid A., Choppin P. Activation of the Sendai virus fusion protein (F) involves a conformational change with exposure of a new hydrophobic region. J. Biol. Chem. 256:1981;3557-3563.
20. Iwata S., Schmidt A. C., Titani K., Suzuki M., Kido H., Gotoh B., Hamaguchi M., Nagai Y. Assignment of disulfide bridges in the fusion glycoprotein of Sendai virus. J. Virol. 68:1994;3200-3206.
21. Junius F. K., O'Donoghue S. I., Nilges M., Weiss A. S., King G. F. High resolution NMR solution structure of the leucine zipper domain of the c-Jun homodimer. J. Biol. Chem. 271:1996;13663-13667.
22. Lamb R. A. Paramyxovirus fusion: A hypothesis of changes. Virology. 197:1993;1-11.
23. Lambert D. M., Barney S., Lambert A. L., Guthrie K., Medinas R., Davis D. E., Bucy T., Erickson J., Merutka G., Petteway S. R. Jr. Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion. Proc. Natl. Acad. Sci. USA. 93:1996;2186-2191.
24. Lupas A. Coiled coils: New structures and new functions. Trends Biochem. Sci. 21:1996;375-382.
25. 1. Virology. 193:1993;997-1000.
26. O'Shea E. K., Rutkowski R., Kim P. S. Mechanism of specificity of the Fos-Jun oncoprotein heterodimer. Cell. 68:1992;699-708.
27. Ptitsyn O. B. Secondary structure formation and stability. Curr. Opin. Struct. Biol. 2:1992;13-20.
28. Rapaport D., Ovadia M., Shai Y. A synthetic peptide corresponding to a conserved heptad repeat domain is a potent inhibitor of Sendai virus-cell fusion: An emerging similarity with functional domains of other viruses. EMBO J. 14:1995;5524-5531.
29. Reitter J., Sergel T., Morrison T. Mutational analysis of the leucine zipper motif in the Newcastle disease virus fusion protein. J. Virol. 69:1995;5995-6004.
30. Rose G. D., Gierasch L. M., Smith J. A. Turns in peptides and proteins. Adv. Prot. Chem. 37:1985;1-106.
31. Scheid A., Choppin P. W. Identification of biological activities of paramyxovirus glycoproteins. Activation of cell fusion, hemolysis, and infectivity by proteolytic cleavage of an inactive protein of Sendai virus. Virology. 57:1974;470-490.
32. Scheid A., Choppin P. W. Two disulfide-linked polypeptide chains constitute active F protein of paramyxoviruses. Virology. 80:1978;51-66.
33. Scholtz J. M., Baldwin R. L. The mechanism of α-helix formation by peptides. Annu. Rev. Biophys. Biomol. Struct. 21:1992;95-118.
34. Segrest J. P., DeLoof H., Dohlman J. G., Brouillette C. G., Anantharamaiah G. M. Amphipathic helix motif: Classes and properties. Proteins. 8:1990;103-117.
35. Sergel T., McGinnes L. W., Morrison T. G. The fusion promotion activity of the NDV HN protein does not correlate with neuraminidase activity. Virology. 196:1993;831-834.
36. Sergel-Germano T., McQuain C., Morrison T. Mutations in the fusion peptide and heptad repeat regions of the Newcastle disease virus fusion protein block fusion. J. Virol. 68:1994;7654-7658.
37. States D. J., Haberkorn R. A., Rubin D. J. A two dimensional nuclear Overhauser experiment with pure absorption phase in four quadrants. J. Magn. Reson. 48:1982;286-292.
38. Toyoda T., Sakaguchi T., Imai K., Inocencio N. M., Gotoh G., Hamaguchi M., Nagai Y. Structural comparison of the cleavage-activation site of the fusion glycoprotein between virulent and avirulent strains of Newcastle disease virus. Virology. 158:1987;242-247.
39. White J. M. Viral and cellular membrane fusion proteins. Annu. Rev. Phys. 52:1990;2887-2896.
40. White J. M. Membrane fusion. Science. 258:1992;917-924.
41. Wild C., Dubay J. W., Greenwell T., T. Baird J., Oas T. G., McDanal C., Hunter E., Mathews T. Propensity for a leucine zipper-like domain of human immunodeficiency virus type 1 gp41 to form oligomers correlates with a role in virus-induced fusion rather than assembly of the glycoprotein complex. Proc. Natl. Acad. Sci. USA. 91:1994a;12676-12680.
42. Wild C., Oas T., McDanal C., Bolognesi D., Mathews T. A synthetic peptide inhibitor of human immunodeficiency virus replication: Correlation between solution structure and viral inhibition. Proc. Natl. Acad. Sci. USA. 89:1992;10537-10541.
43. Wild C. T., Shugars D. C., Greenwell T. K., McDanal C. B., Mathews T. J. Peptides corresponding to a predictive a-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection. Proc. Natl. Acad. Sci. USA. 91:1994b;9770-9774.
44. Wüthrich K. NMR of Proteins and Nucleic Acids. 1986;Wiley, New York.
45. Wüthrich K., Billeter M., Braun W. Polypeptide secondary structure determined by nuclear magnetic resonance observation of short proton-proton distances. J. Mol. Biol. 180:1984;715-740.
46. Yao Q., Compans R. W. Peptides corresponding to the heptad repeat sequence of human parainfluenza virus fusion protein are potent inhibitors of virus infection. Virology. 223:1996;103-112.
47. Young J. K., Anklin C., Hicks R. P. NMR and molecular modeling investigations of the neuropeptide substance P in the presence of 15 mM sodium dodecyl sulfate micelles. Biopolymers. 34:1994;1449-1462.
48. Young J. K., Hicks R. P. NMR and molecular modeling investigations of the neuropeptide bradykinin in three different solvent systems: DMSO, 9:1 dioxane/water, and in the presence of 7.4 mM lysophosphatidylcholine micelles. Biopolymers. 34:1994;611-623.
49. 1. J. Peptide Res. 50:1997;122-131.
50. Zhu N. E., Kay C. M., Syker B. D., Hodges R. S. A single-stranded amphipathic α-helix in aqueous solution. Design, structural characterization, and its application for determining α-helical properties of amino acids. Biochemistry. 32:1993;6190-6197.